Oracle Retreats, Fed Rate Cut Looms, and Vaccine Politics Shake Pharma Stocks Markets closed Friday in mixed fashion as economic uncertainty and politics clashed with earnings optimism. Oracle's rollercoaster continues, RFK Jr. rattles vaccine makers, and the Fed appears poised to begin its rate-cut cycle next week. All this while tech, AI, and takeover buzz kept parts of the market energized.
Synopsys, Chewy, And The Trade Desk Are Among Top 10 Large Cap Losers Last Week (Sep. 8- Sep. 12): Are The Others In Your Portfolio? Earnings misses, weak guidance, and downgrades drove large-cap decliners—led by Synopsys, Chewy, and The Trade Desk—while biotech trial updates and mixed analyst calls pressured others.
Why BioNTech Stock Sank by More Than 7% Today The type of vaccine it's most famous for might be cast in a very unflattering light in the very near future..
Pfizer, Moderna, BioNTech Stocks Tumble After Report Of Plan To Link COVID Vaccines To Child Deaths Shares of COVID-19 vaccine makers are trading lower Friday. Vaccine stocks fell Friday on a Washington Post report that Trump administration officials plan to link the shots to 25 child deaths.
China-Tied Biotechs Zai Labs, BeOne Plunge On Rumored Executive Order Zai Labs and BeOne Medicines plummeted Wednesday on reports an executive order could reduce access to China-developed drugs.
Pfizer, BioNTech Roll Out COVID-19 Update That Boosts Antibodies 4-Fold In High-Risk Adults Pfizer and BioNTech's LP.8.1 COVID-19 vaccine boosts antibodies 4-fold in high-risk adults, with no new safety concerns reported.
BioNTech, Bristol Myers Squibb Show Tumor Shrinkage In Lung Cancer Immunotherapy BioNTech and Bristol Myers report strong interim results for pumitamig plus chemo in lung cancer, showing high response rates.
Summit Therapeutics Crashes After Failing To Deliver Another Merck-Walloping Punch Summit Therapeutics stock crashed Monday after the company's drug failed to meet the bar for overall survival in lung cancer.
Why BioNTech Stock Crushed the Market Today The company might be close to commercializing its most advanced pipeline program.
Shots Fired! After RFK Jr.'s Senate Grilling, Will Pfizer, Moderna Survive The Battle In D.C.? It's unprecedented times for the Covid vaccine market, experts say. And Pfizer and Moderna remain under significant pressure.
BioNTech Surges 10% On Promising Test Results For Its Cancer Smart Bomb The company's DualityBio-partnered drug met the pre-specified bar for success in a pivotal study.
BioNTech Advances On Positive Phase 3 Breast Cancer Drug Data BioNTech and DualityBio reported Phase 3 success for trastuzumab pamirtecan in HER2 breast cancer, setting stage for regulatory submission in China.
Robert Kennedy Jr.'s Leadership Can Only Bring More 'Harm,' Says Top Ex-CDC Official: 'Undoing Of Vaccination' In Works Daskalakis resigned due to political interference in CDC, fears harm will come from new direction. CDC leaders also resign in protest.
RFK Jr. Rescinds Emergency Authorizations For COVID-19 Vaccines FDA approves Pfizer, Moderna, and Novavax Covid vaccines for high-risk groups as emergency authorizations end and vaccines transition to full marketing.
RFK Jr. Makes Good On Promise To End Covid Vaccine Mandate. BioNTech Tumbles. Shares of one vaccine-maker are under pressure on Robert F. Kennedy Jr.'s move on Wednesday.
Trump Administration Plans To Pull COVID-19 Vaccines Off Market 'Within Months' The Trump administration may remove COVID-19 vaccines from the U.S. market as RFK Jr.'s allies gain influence at HHS, with a new vaccine task force led by a known skeptic.
3 Reasons Pfizer's 7%-Yielding Dividend Is Getting Safer This big pharma company's juicy dividend is looking even more attractive.
CDC Shooting Linked To Suspect's COVID-19 Vaccine Beliefs, Former Staff Blame RFK Jr. Hostility Toward Agency CDC shooting tied to anti-vaccine beliefs sparks warnings from staff, as leaders clash over the future of mRNA vaccines and federal health policy.
Former Surgeon General Slams RFK Jr. Over mRNA Cuts, Says US 'Conceding To China,' 2 Million Lives At Risk Adams warns cutting funding for mRNA vaccine research will cost lives, derail medical progress, and give China an advantage.
